Hepatitits C Completed Phase 2 Trials for Simeprevir (DB06290)

IndicationStatusPhase
DBCOND0070848 (Hepatitits C)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02165189An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver TransplantTreatment